DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Frith PA, Thompson PJ, Ratnavadivel R. et al.
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial.
Thorax 2015;
70: 519-527
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.